CANF
Price
$1.09
Change
+$0.02 (+1.85%)
Updated
Jun 6 closing price
Capitalization
14.57M
LGVN
Price
$1.23
Change
+$0.05 (+4.24%)
Updated
Jun 6 closing price
Capitalization
17.71M
Interact to see
Advertisement

CANF vs LGVN

Header iconCANF vs LGVN Comparison
Open Charts CANF vs LGVNBanner chart's image
Can-Fite BioPharma
Price$1.09
Change+$0.02 (+1.85%)
Volume$74.11K
Capitalization14.57M
Longeveron
Price$1.23
Change+$0.05 (+4.24%)
Volume$93.85K
Capitalization17.71M
CANF vs LGVN Comparison Chart
Loading...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANF vs. LGVN commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Buy and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (CANF: $1.07 vs. LGVN: $1.27)
Brand notoriety: CANF and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 25% vs. LGVN: 172%
Market capitalization -- CANF: $14.57M vs. LGVN: $17.71M
CANF [@Biotechnology] is valued at $14.57M. LGVN’s [@Biotechnology] market capitalization is $17.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 0 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • CANF’s FA Score: 0 green, 5 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, LGVN is a better buy in the long-term than CANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 5 TA indicator(s) are bullish while LGVN’s TA Score has 3 bullish TA indicator(s).

  • CANF’s TA Score: 5 bullish, 3 bearish.
  • LGVN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CANF is a better buy in the short-term than LGVN.

Price Growth

CANF (@Biotechnology) experienced а +3.40% price change this week, while LGVN (@Biotechnology) price change was -4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGVN($17.7M) has a higher market cap than CANF($14.6M). LGVN YTD gains are higher at: -26.301 vs. CANF (-34.462). LGVN has more cash in the bank: 19.2M vs. CANF (995K). CANF has less debt than LGVN: CANF (40K) vs LGVN (1.45M).
CANFLGVNCANF / LGVN
Capitalization14.6M17.7M82%
EBITDAN/A-15.56M-
Gain YTD-34.462-26.301131%
P/E RatioN/AN/A-
RevenueN/A2.39M-
Total Cash995K19.2M5%
Total Debt40K1.45M3%
FUNDAMENTALS RATINGS
CANF: Fundamental Ratings
CANF
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CANFLGVN
RSI
ODDS (%)
Bullish Trend 12 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
87%
Momentum
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
82%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Bullish Trend 24 days ago
82%
Declines
ODDS (%)
Bearish Trend 26 days ago
85%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
89%
Aroon
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with LGVN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then LGVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
N/A
LGVN - CANF
35%
Loosely correlated
-4.85%
GBIO - CANF
31%
Poorly correlated
-1.11%
OABI - CANF
28%
Poorly correlated
-3.01%
RNA - CANF
27%
Poorly correlated
+1.81%
KYTX - CANF
27%
Poorly correlated
-1.16%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with RNA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-4.85%
RNA - LGVN
43%
Loosely correlated
+1.81%
BRTX - LGVN
42%
Loosely correlated
-1.84%
CANF - LGVN
35%
Loosely correlated
N/A
SNGX - LGVN
31%
Poorly correlated
+1.05%
XOMA - LGVN
30%
Poorly correlated
+0.92%
More